• 

  EnteroMix cancer vaccine: What Russia’s 100% efficacy claim really means

  Health | September 07, 2025 15:26 IST

  Russia’s EnteroMix cancer vaccine is making headlines for “100% efficacy” in early trials. But experts caution that these are preliminary results from Phase I studies. Here’s what we know so far about EnteroMix, its promise, and why larger trials are crucial before real-world use.

• 

  Maharashtra government to provide free cancer vaccine for girls aged 0-14 across state

  Maharashtra | March 01, 2025 18:34 IST

  The Maharashtra government has decided to implement a free cancer vaccination programme to address the issue.

• 

  Cancer vaccine for women set to be launched in India within 5-6 months, know details

  Health | February 18, 2025 22:30 IST

  In a major development, Union Minister Prataprao Jadhav announced that cancer vaccines for women will be available soon. While there is still much research and testing needed, the use of cancer vaccines holds great promise in the fight against this devastating disease.

• 

  Russia claims it developed first cancer vaccine in big breakthrough, says 'will distribute for free'

  Health | December 19, 2024 18:49 IST

  Russia has claimed that they have innovated a cancer vaccine and they will distribute it for free. However, they haven't been informed about the human trial yet. But with their recent claim, we can see a ray of hope for ending the cancer chapter.

• 

  Putin claims Russia is close to creating cancer vaccines I How will it impact India's medical burden

  World | February 15, 2024 10:13 IST

  Pharmaceutical companies Moderna and Merck & Co are developing an experimental cancer vaccine that a mid-stage study showed to cut the chance of recurrence or death from melanoma - the most deadly skin cancer - by half after three years of treatment.

• 

  Cancer vaccine developed to boost lifespan of patients

  World | October 31, 2013 7:35 IST

  Moscow : Russian scientists have developed a vaccine for the treatment of cancer that can increase the patient's lifespan more than two-fold, ITAR-TASS reported Wednesday.The vaccine, developed at the Institute of Clinical Immunology in the